GEVO insider files Rule 144 to sell 57,651 shares via Stifel Nicolaus

Rhea-AI Filing Summary

Form 144 filed for Gevo, Inc. (GEVO) discloses a proposed sale of 57,651 shares of common stock through Stifel Nicolaus on approximately 08/20/2025 with an aggregate market value of $93,942. The filing shows the shares originated from restricted stock units granted on various dates (08/29/2022, 08/03/2023, 05/22/2024) and that prior sales by the same person occurred on 06/03/2025 (10,810 shares) and 08/05/2025 (5,738 shares) generating gross proceeds of $12,572 and $7,061 respectively. The total shares outstanding reported in the form are 239,562,995, placing this proposed sale as a small fraction of the company’s outstanding common stock. The filer certifies no undisclosed material adverse information and provides broker details for the planned transaction.

Positive

• None.

Negative

• Insider sale disclosed: Proposed sale of 57,651 shares (~$93,942) and prior small sales in June and August 2025 indicate insider dispositions.
• Concentration of grants: Shares to be sold arise from multiple Restricted Stock Unit grants between 2022 and 2024, showing reliance on equity compensation as liquidity source.

Insights

Securities Analyst

TL;DR Insider intends to sell 57,651 shares (~$93.9k) from vested restricted stock units; size is small relative to outstanding shares.

The filing documents a routine Rule 144 notice for sale of shares originating from restricted stock units granted across 2022–2024. Reported prior sales in June and August 2025 indicate some ongoing disposition of holdings. Given the issuer's reported 239.6 million shares outstanding, the proposed 57,651-share sale represents a de minimis percentage and is unlikely to be material to market supply or company valuation. Disclosure appears consistent with Rule 144 requirements and includes broker information and acquisition details.

Corporate Governance Expert

TL;DR Filing is a standard compliance disclosure; it confirms insider liquidity events but shows no sign of coordinated or large-scale unloading.

The form provides transparent information about the source of the securities (restricted stock units) and payment method. Repeated small sales may reflect routine vesting and planned liquidity rather than a change in executive control or governance. The filer's certification that no material nonpublic information is known is present, and a named broker is identified for the transaction. From a governance perspective, this is a routine insider sale disclosure rather than a governance concern.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	57651	93942.00	239562995	08/20/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/29/2022	Restricted Stock Units	Issuer			6610	08/29/2022	Cash
Common Stock	08/03/2023	Restricted Stock Units	Issuer			18223	08/03/2023	Cash
Common Stock	08/29/2022	Restricted Stock Units	Issuer			6610	08/29/2022	Cash
Common Stock	05/22/2024	Restricted Stock Units	Issuer			31958	05/22/2024	Cash
Common Stock	08/03/2023	Restricted Stock Units	Issuer			18223	08/03/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Leke Agiri 345 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	08/05/2025	5738	7061.00
Leke Agiri 345 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	06/03/2025	10810	12572.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for GEVO disclose?

The filing discloses a proposed sale of 57,651 common shares via Stifel Nicolaus with aggregate market value of $93,942, approximate sale date 08/20/2025.

Who is selling the GEVO shares and where did they come from?

The seller is the person named in the form (seller address shown). The shares originate from Restricted Stock Units granted on 08/29/2022, 08/03/2023 and 05/22/2024.

Has the filer sold GEVO shares recently?

Yes. The form reports sales of 10,810 shares on 06/03/2025 (gross proceeds $12,572) and 5,738 shares on 08/05/2025 (gross proceeds $7,061).

How significant is the proposed sale relative to GEVO's outstanding shares?

The form reports 239,562,995 shares outstanding; the proposed 57,651-share sale represents a very small fraction of total outstanding shares.

Which broker is handling the proposed sale?

The broker listed is Stifel Nicolaus & Company Inc, address 501 N Broadway, St. Louis, MO, and the securities exchange listed is Nasdaq.